Thomas C. Freyman - 08 May 2026 Form 4 Insider Report for AbbVie Inc. (ABBV)

Reporting relationship: Director
Issuer ticker: ABBV
Reported as of: 08 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 May 2026, 17:00:13 UTC
Prior SEC filing: 13 May 2025
Source filing: View source filing
Reporting owner signature: /s/ T.O. Odutayo, attorney-in-fact for Thomas C. Freyman

Key filing fact

Thomas C. Freyman filed Form 4 for AbbVie Inc. (ABBV) on 12 May 2026.

Key facts

This page summarizes Thomas C. Freyman's Form 4 filing for AbbVie Inc. (ABBV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 May 2026, 17:00.

Change

Previous filing in this sequence was filed on 13 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239126 Primary reporting owner

FREYMAN THOMAS C

Relationship: Director
Address: 1 N. WAUKEGAN ROAD, NORTH CHICAGO
Signature: /s/ T.O. Odutayo, attorney-in-fact for Thomas C. Freyman
Signature date: 12 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABBV transaction

Common Stock, $0.01 par value

Award

Transaction value
Shares: +1,118
Change %: +0.88%
Price: $0.000000^*
Shares after: 127,869
Date: 08 May 2026
Ownership: Direct
Footnotes: F1

ABBV holding

Common Stock, $0.01 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,000
Date: 08 May 2026
Ownership: By spouse in trust
Footnotes: F2

ABBV holding

Common Stock, $0.01 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,941
Date: 08 May 2026
Ownership: By spouse in trust for son
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Footnote F2

The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.

Footnote F3

Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.